In this response we concentrate on what Weinstein et al. call the 'major disagreement' between the Erasmus group and the US Panel, which concerns the measurement of productivity losses during illness. We consider the consequences for the individual, for the employer and for the rest of society and a
Portfolio Theory and Cost-Effectiveness Analysis: A Further Discussion
β Scribed by Pedram Sendi; Maiwenn J. Al; Frans F. H. Rutten
- Book ID
- 109078447
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 143 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1098-3015
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Cost-effectiveness analysis (CEA) compares the costs and outcomes of two or more technologies. However, there is no consensus about which measure of effectiveness should be used in each analysis. Clinical researchers have to select an appropriate outcome for their purpose, and this choice can have d
## SUMMARY Nord (2011) criticizes standard arguments which assert that consistency requires that future health benefits must be discounted at the same rate as future costs in costβeffectiveness analysis (CEA). He suggests these arguments are misguided because they require transitivity of preference